Global Artificial Intelligence (AI) In Biopharmaceuticals Market
Pharmaceuticals

Unlocking Opportunities in the Artificial Intelligence (AI) In Biopharmaceuticals Market: Key Trends, Market Growth, and Forecast Insights

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Drivers Are Shaping the Growth and Development of theArtificial Intelligence (AI) In Biopharmaceuticals Market?

The escalating incidences of chronic ailments are anticipated to drive the expansion of the artificial intelligence (AI) in biopharmaceuticals market in the future. Chronic diseases refer to long-term conditions that generally progress at a slow pace and could last for a prolonged number of years or even a lifetime. They stem from lifestyle factors, an aging demographic, genetic inclinations, and environmental influences. AI in biopharmaceuticals is increasingly utilized to handle chronic diseases since it assesses a vast amount of varied data sources, recognizes patterns, and personalizes treatment methods. For example, the Department of Health and Human Services stated in November 2023 that there was an 11 percent rise in new chronic hepatitis B cases in 2022 compared to 2021. Therefore, the escalating incidences of chronic diseases enhances the growth of artificial intelligence (AI) in the biopharmaceuticals market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14251&type=smp

#What is the Growth Potential of the Artificial Intelligence (AI) In Biopharmaceuticals Market, and How Will It Perform by 2034?

Recent years have seen a significant expansion in the market size for artificial intelligence (AI) in biopharmaceuticals. The market is predicted to increase from $1.59 billion in 2024 to about $2.12 billion in 2025, reflecting a compound annual growth rate (CAGR) of 33.1%. This remarkable growth during the historical period can be ascribed to factors such as enhanced computational capacity, a surge in biomedical data, the precision medicine model, and regulatory backing and guidance.

The market size of artificial intelligence (AI) in the biopharmaceutical industry is predicted to witness immense growth in the upcoming years, escalating to a value of $6.67 billion by 2029 with a compound annual growth rate (CAGR) of 33.2%. This growth in the outlook period can be ascribed to enhancements in computational biology, the amalgamation of diversified data, the intersection of AI and life sciences, supportive regulatory frameworks, and principles of ethical and fair AI. The forecast period will see dominant trends like the integration of multi-omics data, AI-infused drug design and discovery, understandable AI and regulatory approval, advancements in technology, regulatory changes, and the advent of new opportunities.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14251

Which Cutting-Edge Market Trends Are Expected to Drive theArtificial Intelligence (AI) In Biopharmaceuticals Market’s Growth?

Leading companies involving in the biopharmaceutical sector of artificial intelligence (AI) are primarily focusing their attention on creating revolutionary enhancements such as AI-integrated solutions for target and lead identification to speed up precision medicine and drug discovery, consequently transforming organizations within the life sciences realm. These innovative solutions for precision medicine and drug discovery encompass multiple approaches towards generating new medications and personalizing treatments for individual patients. For instance, in May 2023, Google LLC, a renowned provider of cloud computing services based in the US, rolled out two new AI-integrated tools, namely target and lead identification suites. These tools are designed to aid researchers in prediction and understanding of protein structures, an indispensable part of drug development. Moreover, this suite will also assist researchers in the intake, storage, analysis, and sharing of large volumes of genomic data, which is vital for precision medicine. Therefore, these tools function with the objective to optimize the process of drug discovery, lower costs, and expedite the introduction of new treatments in the market. By delivering efficient management of data, accurate prediction of protein structures and enhanced capabilities for genomic analysis, these tools seek to revolutionize the process of drug development and consequently, improve patient results.

What Are the Leading Market Players Impacting theArtificial Intelligence (AI) In Biopharmaceuticals Market’s Growth Trend?

Major companies operating in the artificial intelligence (AI) in biopharmaceuticals market are Apple Inc., Google LLC, Microsoft Corporation, Tencent Holdings Limited, Amazon Web Services Inc., International Business Machines Corporation, Exscientia Limited, NVIDIA Corporation, Amgen Inc., DeepMind Technologies Limited, Schrödinger Inc., XtalPi Inc., ConcertAI Inc., Insilico Medicine Inc., Recursion Pharmaceuticals, BenevolentAI, BioXcel Therapeutics, Atomwise Inc., BioAge Labs Inc., GNS Healthcare, Berg Health, Deep 6 AI Inc., Cloud Pharmaceuticals Inc., Numerate Inc., AI Therapeutics, Envisagenics, twoXAR Inc., Cyclica Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-biopharmaceuticals-global-market-report

How Are the Key Segments of the Artificial Intelligence (AI) In Biopharmaceuticals Market Driving Opportunities and Innovations?

The artificial intelligence (AI) in biopharmaceuticals market covered in this report is segmented –

1) By Offering: Hardware, Software, Services

2) By Deployment: Cloud, On-Premises

3) By Technology: Machine Learning, Natural Language Processing, Deep Learning, Other Technologies

4) By Application: Business Process And Supply Chain, Drug Discovery, Medical Imaging And Diagnostics, Precision Medicine

5) By End-Users: Manufacturers, Contract Research Organizations, Academic And Government Research Institutes

Subsegments:

1) By Hardware: High-Performance Computing Systems, AI-Enabled Laboratory Equipment, Data Storage Solutions

2) By Software: Drug Discovery Platforms, Clinical Trial Management Software, Predictive Analytics Tools, Natural Language Processing Solutions

3) By Services: Consulting Services, Implementation And Integration Services, Data Management And Analytics Services, Training And Support Services

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=14251&type=smp

What Regions Are At the Forefront of #What Drivers Are Shaping the Growth and Development of theArtificial Intelligence (AI) In Biopharmaceuticals Market?# Market Expansion?

North America was the largest region in the artificial intelligence (AI) in biopharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in biopharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Artificial Intelligence (AI) In Biopharmaceuticals Market 2025, By The Business Research Company:

Artificial Intelligence in Healthcare Diagnosis Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-healthcare-diagnosis-global-market-report

Artificial Intelligence (AI) In Industrial Machinery Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-industrial-machinery-global-market-report

Artificial Intelligence (AI) in Operating Room Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-operating-room-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Leave a Reply

Your email address will not be published. Required fields are marked *